Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Devices for tachycardia termination.

M A de Belder1, A J Camm

  • 1Department of Cardiological Sciences, St George's Hospital Medical School, London, United Kingdom.

The American Journal of Cardiology
|December 5, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adverse effects of amiodarone at low dose: plus ça change.

Journal of the American College of Cardiology·1997
Same author

Atrial premature beats preceding episodes of paroxysmal atrial fibrillation: factorial analysis of a prediction system.

Pacing and clinical electrophysiology : PACE·1997
Same author

Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy.

Japanese circulation journal·1997
Same author

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

Circulation·1997
Same author

Chlamydia pneumoniae and coronary heart disease.

BMJ (Clinical research ed.)·1997
Same author

Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.

Lancet (London, England)·1997
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Significant progress in tachyarrhythmia management over 20 years includes improved implantable devices and ablation techniques. These advancements enhance safety and efficacy in treating various heart rhythm disorders.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Technology

Background:

  • Tachyarrhythmias pose significant clinical challenges.
  • Past treatments like antitachycardia pacemakers had limitations, especially for ventricular tachycardia.
  • Recent decades have seen rapid advancements in cardiac rhythm management.

Purpose of the Study:

  • To review the advancements in tachyarrhythmia management over the last two decades.
  • To highlight progress in drug therapy, surgical and catheter ablation, and implantable devices.
  • To discuss improvements in the safety and efficacy of treating ventricular tachycardia.

Main Methods:

  • Review of recent literature and technological developments in tachyarrhythmia management.
  • Analysis of progress in drug development, ablation techniques, and implantable device technology.

Related Experiment Videos

  • Evaluation of improvements in arrhythmia detection, termination algorithms, and defibrillation.

    • Main Results:

    • Development of new antiarrhythmic drugs.
    • Refinement of catheter ablation and surgical techniques for rhythm control.
    • Significant improvements in implantable devices, including enhanced arrhythmia detection, adaptable termination algorithms, and automatic cardioversion/defibrillation for malignant ventricular arrhythmias.
    • Increased safety and efficacy of pacing therapies.

    Conclusions:

    • The last two decades have yielded remarkable advances in managing tachyarrhythmias.
    • Implantable devices have evolved significantly, offering safer and more effective treatment options.
    • Continued innovation in technology and therapeutic strategies promises further improvements in patient outcomes for cardiac rhythm disorders.